Citicoline Linked With Slower Progression of Glaucoma
Glaucoma is a disease that attacks the optic nerve and can lead to blindness in as little as two years. A recent study suggests that taking supplements of the nutrient citicoline – more commonly known for its effects on brain health – may slow down the progression of glaucoma.
Participants in the study included 41 individuals with primary open-angle glaucoma (POAG), which is characterized by high intraocular pressure and subsequent loss of vision. Over the course of two years they were given an oral solution containing 500 mg of citicoline daily.
At the conclusion of the study, the researchers found that the disease progressed significantly slower and that intraocular pressure dropped from an average of 18 mm HG to 15.5 mm HG.
The researchers could not say definitively that these effects were due to the citicoline alone but noted that there was a clear correlation.
Researchers from the Sao Paolo Hospital Eye Clinic at the University of Milan conducted the study. It was published online ahead of print on April 23, 2013, in the journal Ophthalmologica.
Previous studies have linked citicoline intake with brain health, improved memory and decreased cognitive functino. It has been shown to generate electrical impulses in the brain, help keep brain cells healthy, and protect neurons from free radical damage.